Evaluation of bovine lactoferrin as a topical therapy for chemotherapy- induced mucositis in the golden Syrian hamster

Oral Oncology

Volumn 35, Issue 2, 1999, Pages 197-202

  Clarke, Julie ^a   Edwards, Ben ^a   Srpek, Leanne ^a   Regester, Geoff ^a  

^a CHILD HEALTH RESEARCH INSTITUTE   (Australia)

Author keywords

Antimicrobial; Immune; Lactoferrin; Mucositis; Therapy; Ulceration

Indexed keywords

BOVINE SERUM ALBUMIN; FLUOROURACIL; LACTOFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEEK POUCH; CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNE DEFICIENCY; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOPENIA; MALE; MOUTH MUCOSA; MOUTH ULCER; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER; TOPICAL DRUG ADMINISTRATION; TREATMENT FAILURE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CHEEK; CRICETINAE; DRUG EVALUATION; FLUOROURACIL; IMMUNOCOMPROMISED HOST; LACTOFERRIN; LEUKOPENIA; MESOCRICETUS; MOUTH MUCOSA; STOMATITIS; WOUND HEALING;

EID: 0033040403     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00087-6     Document Type: Article

References (23)

1. Mueller BA, Millheim ET, Farrington EA, Brusko C, Wiser TH. Mucositis management practices for hospitalized patients: National survey results. J Pain and Symptom Management 1995; 10:510-18.
2. Mueller BA, Millheim ET. Pharmaceutical aspects of mucositis mouthwash mixtures. Amer J Health System Pharmacy 1995; 52:2596-7.
3. Epstein JB, Stevenson-Moore P, Jackson S, Mohamed JH, Spinelli JJ. Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse. Internat J Radiation Oncology Biology and Physics 1989;16:1571-5.
4. Kannan V, Bapsy PP, Anantha N et al. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma. Internat J Radiation Oncology Biology and Physics 1997;37(5):1005-10.
5. Sonis ST, Van Vugt AG, Brien JPO, Muska AD, Bruskin AM, Rose A, Haley JD. Transforming growth factor-β3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis. Oral Oncology 1977;33(1):47-54.
6. Sonis ST, Tracey C, Shklar G, Jenson J, Florine D. An animal model for mucositis induced by cancer chemotherapy. Oral Surgery, Oral Medicine, Oral Pathology 1990;69:437-43.
7. Donovan SM, Odle J. Growth factors in milk as mediators of infant development. Ann Rev Nutrition 1994;14:147-67.
8. Belford DA, Rogers M, Regester GO, Smithers GW, Liepe IJ, Priebe IK, Ballard FJ. Milk-derived growth factors as serum supplements for the growth of fibroblast and epithelium cells. In Vitro Cellular and Developmental Biology 1995;31:752-60.
9. Dionysius DA, Grieve PA, Milne JM. Forms of lactoferrin: their antibacterial effect on enterotoxigenic Escherichia coli. J Dairy Sci 1993;76:2597-606.
10. Wakabayashi H, Bellamy W, Takase M, Tomita, M. Inactivation of Listeria monocytogenes by lactoferrin, a potent antimicrobial peptide derived from cow's milk. J Food Protection 1992; 55:238-40.
11. Hagiwara T, Shinoda I, Fukuwatari Y, Shimamura. Effects of lactoferrin and its peptides on proliferation of rat intestinal epithelial cell line, IEC-18, in the presence of epidermal growth factor. Bioscience Biotechnology Biochemistry 1995;59(10):1875-81.
12. Baynes RD, Bezwoda WR. Lactoferrin and the inflammatory response. In: Hutchen TW et al., editor. Lactoferrin: Structure and Function, vol. 357. Advances in Experimental Medicine and Biology, New York: Plenum Press, 1994:133-41.
13. Sato R, Inanami O, Tanaka Y, Takase M, Naito Y. Oral administration of bovine lactoferrin for treatment of intractable stomatitis in feline immunodeficiency virus (FIV)-positive and FIV-negative cats. Amer J Veterinary Res 1996;57(10):1443-6.
14. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica 1995;80(3):252-67.
15. Hutchens WT, Rumball SV, Lonnerdal B. Lactoferrin: Structure and Function. In: Hutchen TW et al., editor. Lactoferrin: Structure and Function, vol.357. Advances in Experimental Medicine and Biology, New York: Plenum Press, 1994.
16. Brock, J. Lactoferrin: a multifunctional immunoregulatory protein? Immunology Today 1995;16(9):417-9.
17. Hashizume S, Kuroda K, Murakami H. Identification of lactoferrin as an essential growth factor for human lymphocytic cell lines in serum-free medium. Biochemica et Biophysica Acta 1983;763:377-82.
18. Roiron D, Amouric M, Marvaldi J, Figarella C. Lactoferrin-binding sites at the surface of HT29-D4 cells, comparison with transferrin. European J Biochemistry 1989;186:367-73.
19. Hanson LA, Mattsby-Baltzer I, Engberg I, Roseanu A, Elverfors J, Motas C. Anti-inflammatory capacities of human milk: lactoferrin and secretory IgA inhibit endotoxin-induced cytokine release. In: Mestecky J et al., editors. Advances in Mucosal Immunology. New York: Plenum Press, 1995:669-72.
20. Torre PM, Oliver SP. Inhibition of bovine peripheral blastogenesis by fractional mammary secretion. Comparative Biochemistry and Physiology B 1989;92:157-65.
21. Rejman JJ, Payne KD, Lewis MJ, Torre PM, Muenchen RA, Oliver SP. Identification of whey proteins that influence bovine blood mononuclear cell proliferation. J Dairy Sci 1992;75 Suppl 308.
22. Rejman JJ, Oliver SP, Muenchen RA, Turner JD. Proliferation of the MAC-T bovine mammary epithelial cell line in the presence of mammary secretion whey proteins. Cell Biology Internat Rep 1992;16:993-1001.
23. Britigan BE, Edeker BL. Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation. J Clinical Investigation 88:1092-102.